| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 148.32B | 155.50B | 146.67B | 140.57B | 131.91B | 125.09B |
| Gross Profit | 18.50B | 19.91B | 18.22B | 17.43B | 15.46B | 14.81B |
| EBITDA | 21.27B | 21.62B | 20.77B | 19.58B | 17.99B | 17.40B |
| Net Income | 9.27B | 10.72B | 8.93B | 8.30B | 7.40B | 7.12B |
Balance Sheet | ||||||
| Total Assets | 160.71B | 172.36B | 159.45B | 154.89B | 143.04B | 135.67B |
| Cash, Cash Equivalents and Short-Term Investments | 21.64B | 26.51B | 23.64B | 26.41B | 25.24B | 19.60B |
| Total Debt | 24.24B | 31.51B | 30.53B | 29.75B | 27.97B | 28.99B |
| Total Liabilities | 57.55B | 61.24B | 57.55B | 59.26B | 54.88B | 54.08B |
| Stockholders Equity | 90.77B | 97.95B | 89.56B | 83.94B | 77.38B | 71.56B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.12B | 1.83B | 7.67B | 11.30B | 8.11B |
| Operating Cash Flow | 0.00 | 19.97B | 14.11B | 15.88B | 13.65B | 13.60B |
| Investing Cash Flow | 0.00 | -10.59B | -11.08B | -8.30B | -3.00B | -6.03B |
| Financing Cash Flow | 0.00 | -6.24B | -5.55B | -6.50B | -5.77B | -4.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥144.82B | 12.20 | ― | 2.12% | 6.02% | 20.59% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥307.18B | 26.94 | ― | 1.28% | 6.67% | 10.43% | |
60 Neutral | ¥943.35B | 15.06 | 9.97% | 3.54% | 11.19% | 5.65% | |
59 Neutral | ¥334.63B | 18.56 | 8.30% | 2.50% | 5.27% | -5.79% | |
59 Neutral | ¥297.34B | 17.48 | ― | 2.94% | 1.47% | -10.54% | |
56 Neutral | ¥1.19T | 47.02 | ― | 2.99% | -0.90% | -81.16% |